ANGO (STOCKS)
AngioDynamics, Inc.
$15.660000
-0.090000 (-0.57%)
Prev close: $15.750000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- James Christopher Clemmer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $671.58M
- Employees
- 675
- P/E (TTM)
- -17.79
- P/B (TTM)
- 3.84
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $320.17M |
| Benefits Costs and Expenses | $356.47M |
| Cost Of Revenue | $145.28M |
| Costs And Expenses | $356.47M |
| Gross Profit | $174.89M |
| Operating Expenses | $214.82M |
| Depreciation and Amortization | $22.96M |
| Research and Development | $29.45M |
| Other Operating Expenses | $162.42M |
| Operating Income/Loss | -$39.93M |
| Income/Loss From Continuing Operations After Tax | -$36.74M |
| Income/Loss From Continuing Operations Before Tax | -$36.30M |
| Income Tax Expense/Benefit | $442.00K |
| Income Tax Expense/Benefit, Current | $299.00K |
| Income Tax Expense/Benefit, Deferred | $143.00K |
| Net Income/Loss | -$36.74M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$36.74M |
| Net Income/Loss Available To Common Stockholders, Basic | -$36.74M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.88 |
| Diluted Earnings Per Share | -$0.88 |
| Basic Average Shares | 41,526,000 |
| Diluted Average Shares | 41,526,000 |
| Assets | $267.16M |
| Current Assets | $163.39M |
| Inventory | $52.44M |
| Other Current Assets | $110.96M |
| Noncurrent Assets | $103.77M |
| Fixed Assets | $27.10M |
| Intangible Assets | $67.21M |
| Other Non-current Assets | $9.46M |
| Liabilities | $96.34M |
| Current Liabilities | $74.72M |
| Accounts Payable | $31.51M |
| Wages | $24.87M |
| Other Current Liabilities | $18.34M |
| Noncurrent Liabilities | $21.62M |
| Equity | $170.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $170.83M |
| Liabilities And Equity | $267.16M |
| Net Cash Flow From Operating Activities | $3.09M |
| Net Cash Flow From Operating Activities, Continuing | $3.09M |
| Net Cash Flow From Investing Activities | -$5.95M |
| Net Cash Flow From Investing Activities, Continuing | -$5.95M |
| Net Cash Flow From Financing Activities | $564.00K |
| Net Cash Flow From Financing Activities, Continuing | $564.00K |
| Exchange Gains/Losses | $267.00K |
| Net Cash Flow | -$2.03M |
| Net Cash Flow, Continuing | -$2.30M |
| Comprehensive Income/Loss | -$27.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$27.04M |
| Other Comprehensive Income/Loss | $9.70M |